The epidemiology of psychotropic drug use in children and adolescents

References

• Abi Khaled, L., Ahmad, F., Brogan, T., Fearnley, J., Graham, J., Macleod, S., et al. (2003). Prescription medicine use by one million Canadian children. Paediatrics & Child Health, 8 (Suppl A), 34A–42A.
   Google Scholar
• American Academy of Child and Adolescent Psychiatry (1998). Practice parameters for the assessment and the treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy Children Adolescents Psychiatry, 37 (10S), 27S–45S.
   Google Scholar
• American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV-TR). Washington DC: American Psychiatric Association.
   Google Scholar
• Arnold, L. E. (2000). Methylphenidate vs. amphetamine: com-parative review. Journal of Attention Disorder, 3,200–211.
   Google Scholar
• Barbaresi, W., Katusic, S., Colligan, R., Weaver, A., Pankratz, V., Mrazek, D., et al. (2004). How common is attention-deficit/ hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatrica, 445, 55–59.
   Google Scholar
• Banaschewski T., Roessner, V., Dittmann, R. W., Santosh, P. J., & Rothenberger, A. (2004). Non-stimulant medications in the treatment of ADHD. European Child and Adolescent Psychiatry, 13, 1/102–1/116.
   Google Scholar
• Barrickman, L. L., Perry, P. J., Allen, A. J., Kuperman, S., Arndt, S. V., Hen-mann, K. J., et al. (1995). Bupropion versus methylphenidate in the treatment of attention-deficit hyper-activity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 649–657.
   Google Scholar
• Biederman, J., Heiligenstein, J. H., Faries, D. E., Galil, N., Dittmann, R., Emslie, G. J., et al., SE the Atomoxetine ADHD Study Group. (2002). Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder. Pediatrics, 110, 6. URL: http://www.pediatric.org/cgi/content/ ful1/110/6/e75 (accessed in April 2005).
   Google Scholar
• Birmaher, B., Ryan, N. D., Williamson, D. E., Brent, D. A., Kaufman, J., Dahl, R. E., et al. (1996). Childhood and adolescent depression: a review of the past 10 years. Part I.
   Google Scholar
• Journal of American Academic Adolescent Psychiatry, 35, 1427-1439.
   Google Scholar
• Bonati, M. (1994). Epidemiologic evaluation of drug use in children. Journal of Clinical Pharmacology, 34, 300-305. Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 29, 773–781.
   Google Scholar
• Brent, D. A., & Birmaher, B. (2002). Adolescent depression. New England Journal of Medicine, 347, 667–671.
   PubMed Web of Science ®Google Scholar
• Brown, T. E. (1995). Attention-deficit disorders and comorbidities in children, adolescents, and adults (First Edition). Washington, DC: American Psychiatric Press.
   Google Scholar
• Charach, A., Ickowicz, A., & Schachar, R. (2004). Stimulant treatment over five years: adherence, effectiveness, and adverse effects. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 559–567.
   PubMed Web of Science ®Google Scholar
• Clavenna, A., Bonati, M., Rossi, E., & De Rosa, M. (2004). Increase in non-evidence based use of antidepressants in children is cause for concern. British Medical Journal, 328, 711–712.
   Google Scholar
• Committee on Safety of Medicines. (2003). Selective serotonin reuptake inhibitors. Use in children and adolescents with major depressive disorder. 10 December 2003 available at URL http:// www.mca.gov.uk/ourwork/monitorsafequalmed/safetymessages/ cemssri_101203.pdf (accessed in April 2005).
   Google Scholar
• Conners, C. K., Casat, C. D., Gualtieri, C. T., Weller, E., Reader, M., Reiss, R. A., et al. (1996). Bupropion hydro-chloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1314–1321.
   PubMed Web of Science ®Google Scholar
• Connor, D. F., Fletcher, K. E., & Swanson, J. M. (1999). A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1551–1559.
   PubMed Web of Science ®Google Scholar
• Delate, T., Gelenberg, A. J., Simmons, V. A., & Motheral, B. R. (2004). Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatric Services, 55, 387–391.
   PubMed Web of Science ®Google Scholar
• Editorial (2004). Limited data suggest that the long-term use of stimulants in children with attention-deficit hyperactivity disorder is effective and safe. Drugs & Therapy Perspectives, 20, 14–16.
   Google Scholar
• Food and Drug Administration (2004a). Public Health Advisory, 15 October 2004. Suicidality in children and adolescents being treated with antidepressant medications. URL: http://www.fda. gov/cder/drug/antidepressants/SSRIPHA200410.htm (accessed in April 2005).
   Google Scholar
• Food and Drug Administration (2004b). New Warning for Strattera. URL: http://www.fda.gov/bbs/topics/ANSWERS/ 2004/anso1335.html (accessed in April 2005).
   Google Scholar
• Food and Drug Administration (2003a). Talk paper FDA approves Prozac for pediatric use to treat depression and OCD available at URL: http://www.fda.gov/bbs/topics/ANSWERS/ 2003/ANS01187.html (accessed in April 2005).
   Google Scholar
• Food and Drug Administration, Center for Drug Evaluation and Research (2003b). Statistical review of Prozac for pediatric OCD and depression. URL: http://www.fda.gov/cder/foi/nda/ 2003/18936S064_Prozac%20Pulvules_statr.pdf (accessed in April 2005).
   Google Scholar
• Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., et al. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry, 160, 1919–1928.
   PubMed Web of Science ®Google Scholar
• Hammad, T. A. (2004). Relationship between psychotropic drugs and pediatric suicidality. URL: http://www.fda.gov/ohrms/ dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf (accessed in April 2005).
   Google Scholar
• Hazell, P., O'Connell, D., Heathcote, D., & Henry, D. (2002). Tricyclic drugs for depression in children and adolescents. The Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD002317. DOI: 10.1002/14651858.CD002317.
   Google Scholar
• Hechtman, L., & Greenfield, B. (2003). Long-term of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Pediatric Drugs, 5, 787–794.
   PubMedGoogle Scholar
• Jureidini, J. N., Doecke, C. J., Mansfield, P. R., Haby, M. M., Menkes, D. B., & Tonkin, A. L. (2004). Efficacy and safety of antidepressants for children and adolescents. British Medical Journal, 328, 879–883.
   PubMed Web of Science ®Google Scholar
• Karno, M., Goldin J. M., Sorenson, S. B., & Burnam, A. (1988). The epidemiology of obsessive-compulsive disorder in five UD communities. Archives of General Psychiatry, 45, 1094–1099.
   Google Scholar
• Kelsey, D. K., Summer, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., et al. (2004). Once-daily atomoxetine treatment for children with attention-deficit/ hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Peditrics, 114, e 1 -e8. URL: http ://www.pediatrics org/ cgi/content/ful1/114/1/e 1 (accessed in April 2005).
   Google Scholar
• Kessler, R. C., Avenevoli, S., & Merikangas, K. R. (2001). Mood disorders in children and adolescents: an epidemiologic perspective. Biological Psychiatry, 49, 1002–1014.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., & Walters, E. E. (1998). Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depression and Anxiety, 7, 3–14.
   PubMedGoogle Scholar
• Kratochvil, C. J., Heiligenstein, J. H., Dittmann, R., Spencer, T. J., Biederman, J., Wernicke, J., et al. (2002). Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 776–784.
   PubMed Web of Science ®Google Scholar
• Kutcher, S., Aman, M., Brooks, S. J., Buitelaar, J., Van Daalen, E., Fegert, J., et al. (2003). International consensus state-ment on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implica-tions and treatment practice suggestions. European Neuropsychopharmacology, 14, 11–28.
   Google Scholar
• Laughren, T. P. (2004). Memorandum, Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research.
   Google Scholar
• URL:http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-04-Tab02-Laughren-Jan5.pdf (accessed in April 2005).
   Google Scholar
• Lord, J., & Paisley, S. (2000). The clinical effectiveness and cost-effectiveness of methylphenidate for hyperactivity in childhood. London: National Institute for Clinical Excellence, version 2.
   Google Scholar
• March, J., Silva, S., Petrycki S., Curry, J., Wells, K., Fairbank, J., et al. (2004). Fluoxetine, cognitive-behavioural therapy and their combination for adolescents with depression. Journal of the American Medical Association, 292, 807–820.
   Google Scholar
• MTA Cooperative Group (2004a). National institute of mental health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics, 113, 754–761.
   PubMed Web of Science ®Google Scholar
• MTA Cooperative Group (2004b). National institute of mental health multimodal treatment study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762–769.
   PubMed Web of Science ®Google Scholar
• Matza, L. S., Rentz, A. M., Secnik, K., Swensen, A. R., Revicki, D. A., Michelson, D., et al. (2004). The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. Developmental and Behavioral Pediatrics, 25, 166–174.
   PubMed Web of Science ®Google Scholar
• Michelson, D., Buitelaar, J. K., Danckaerts, M., Gillberg, C., Spencer, T. J., Zuddas, A., et al. (2004). Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 896–904.
   PubMed Web of Science ®Google Scholar
• Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., et al. (2002). Once-daily atomoxedne treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. American Journal of Psychiatry, 159, 1896–1901.
   PubMed Web of Science ®Google Scholar
• Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., et al., and The Atomoxetine ADHD Study Group. (2001). Atomoxedne in the treatment of children and ado-lescents with attention-deficit/hyperactivity disorder: A ran-domized, placebo-controlled, dose-response study. Paediatrics, 108, 5. URL: http://www.pediatrics.org/cgi/content/ful1/108/5/ e83. (accessed in April 2005.)
   Google Scholar
• Murray, M. L., De Vries, C. S., & Wong, I. C. K. (2004). A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Archives Disease in Childhood, 89, 1098–1102.
   Google Scholar
• Prince, J. B., Wilens, T. E., Biederman, J., Spencer, T. J., & Wozniak, J. R. (1996). Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. Journal of the American Academy of Child and Adolescent Psychiatry, 35,599–605.
   PubMed Web of Science ®Google Scholar
• Ramchandani, P. (2004). Treatment of major depressive disorder in children and adolescents. British Medical Journal, 328, 3–4.
   Google Scholar
• Ramchandani, P., Joughin, C., & Zwi, M. (2003). Attention deficit hyperactivity disorder. Clinical Evidence, 9,318–327.
   Google Scholar
• Rappley, M. D. (2005). Attention deficit-hyperactivity disorder. The New England Journal of Medicine, 352, 165–173.
   PubMed Web of Science ®Google Scholar
• Rey, J. M., & Sawyer, M. G. (2003). Are psychostimulant drugs being used appropriately to treat child and adolescent disorders? British Journal of Psychiatry, 182, 284–286.
   Google Scholar
• Richardson, L. P., Di Giuseppe, D., Christakis, D. A., McCauley, E., & Katon, W. (2004). Quality of care for Medicaid-covered youth treated with antidepressant therapy. Archives General Psychiatry, 61, 475–480.
   Google Scholar
• Rushton, J. L., Fant, K. E., & Clark, S. J. (2004). Use of practice guidelines in the primary care of children with attention-deficit/ hyperactivity disorder. Pediatrics, 114, e23-e28. URL: http://www.pediatrics.orgicgi/content/ful1/114/1/e23. (accessed in April 2005.)
   Google Scholar
• Schirm, E., Tobi, H., Magno Zito, J., SE De-Jong-Van Den Berg, L. T. W. (2001). Psychotropic medication in children: A study from the Netherlands. Pediatrics, 108, e25. URL: http:// www.pediatrics.orgicgi/content/ful1/108/2/e25. (accessed in April 2005.)
   Google Scholar
• Shireman, T. I., Olson, B. M., & Dewan, N. A. (2002). Patterns of antidepressant use among children and adolescents. Psychiatric Services, 53,1444–1450.
   PubMed Web of Science ®Google Scholar
• Spencer, T., Heiligenstein, J. H., Biederman, J., Faries, D. E., Kratochvil, C. J., Conners, C. K., et al. (2002). Results from two proof-of-concept, placebo-controlled studies of atom-oxetine in children with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63,1140–1147.
   PubMed Web of Science ®Google Scholar
• Stewart, S. E., Geller, D. A., Jenike, M., Shaw, D., Mullin, B., SE Faraone, S. V. (2004). Long-term outcome of paediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatrica Scandinavica, 110, 4–13.
   PubMed Web of Science ®Google Scholar
• Swanson, J. M., McBurnett, K., Wigal, T., Pfiffner, L. J., Lerner, M. A., Williams, L., et al. (1993). Effect of stimulant medication on children with attention deficit disorder: a review of reviews. Exceptional Children, 60, 154–162.
   Web of Science ®Google Scholar
• The Clomipramine Collaborative Study Group (1991). Clomipramine in the treatment of patients with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 730–738.
   PubMed Web of Science ®Google Scholar
• Weintrob, N., Cohen, D., Klipper-Aurbach, Y., SE Dickerman, Z. (2002). Decreased growth during therapy with selective serotonin reuptake inhibitors. Archives of Pediatrics & Adolescent Medicine, 156, 696–701.
   Google Scholar
• Wernicke, J. F., Adler, L., Spencer, T., West, S. A., Allen, A. J., Heilingenstein, J., et al. (2004). Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment. Journal Clinical Psychopharmacology, 24, 30–35.
   PubMed Web of Science ®Google Scholar
• Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet, 363, 1341–1345.
   PubMed Web of Science ®Google Scholar
• Wilens, T. E., Biederman, J., Kwon, A., Chase, R., Greenberg, L., Mick, E., et al. (2003). A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. Journal of Child and Adolescent Psychopharmacology, 13, 143–152.
   PubMed Web of Science ®Google Scholar
• Williams, J., Klinepeter, K., Palmes, G., Pulley, A., & Meschan, J. (2004). Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics, 114, 601–606.
   PubMed Web of Science ®Google Scholar
• Woodruff, T. J., Axelrad, D. A., Kyle, A. D., Nweke, 0., Miller, G. G., & Hurley, B. J. (2004). Trends in environmentally related childhood illnesses. Pediatrics, 113, 1133–1140.
   Google Scholar
• Wolraich, M. J. (2003). Annotation: the use of psychotropic medications in children. An American view. Journal of Child Psychology and Psychiatry, 44, 159–168.
   Google Scholar
• World Health Organization (1993). International Classification of Diseases, 10th Edition (ICD10), Geneva.
   Google Scholar